Tango Therapeutics, Inc.

US$21.50As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TNGXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR 12.70%
Div yield —
ROE (21.34%)
Biotechnology
Beta (5Y) 1.22
PE TTM —
TSR TTM 165.10%
Mkt cap US$3.625B
ROIC (13.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$25
17.48%
(35.78%)
Hold 12|4|10|9|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.26
0.27
0.28
44.33%
26.47%
24.72%
15.91%
Revenue$M
232.3
242.5
250.4
244.4
6.04%
11.40%
15.05%
10.94%
Peers (US$3.625B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.241
0.034
0.033
EBIT/Intx
7.939
0.225
0.228
Own earn%
(3.44)
(167.65)
(158.74)
Sh yield%
40.51
31.28
31.25
Owners
Insiders/Inst%
3.49
34.74
Short interest%
1.20
SBC / revenue%
4.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
26–33
$1 testx
—
Incr. ROIC%
6